These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12705121)

  • 1. Absorption of intact nanopeptides in an isolated loop of the rat small intestine: an in vivo study.
    Natochin Y; Prutskova NP; Shakhmatova EI; Gruzdkov AA; Gromova LV
    Dokl Biol Sci; 2003; 388():18-20. PubMed ID: 12705121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antidiuretic reaction of the human and rat kidney to peroral administration of arginine-vasopressin and desmopressin].
    Natochin IuV; Grigor'ev AI; Buravkova LB; Larina IM; Prutskova NP; Shakhmatova EI
    Ross Fiziol Zh Im I M Sechenova; 2003 Feb; 89(2):184-92. PubMed ID: 12710188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
    Vilhardt H; Bie P
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro intestinal transport of vasopressin and its analogues.
    Vilhardt H; Lundin S
    Acta Physiol Scand; 1986 Apr; 126(4):601-7. PubMed ID: 3716836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vasopressin and atrial natriuretic factor in response to head-out water immersion.
    Thornton RM; Krasney JA; Hong SK
    J Appl Physiol (1985); 1993 Oct; 75(4):1917-8. PubMed ID: 8282651
    [No Abstract]   [Full Text] [Related]  

  • 6. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple faces of the vasopressin receptors.
    Vallotton MB
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):C73-6. PubMed ID: 1657657
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylated peptide hormones: pharmacological properties and conformational studies of analogues of [1-desamino,8-D-arginine]vasopressin.
    Kihlberg J; Ahman J; Walse B; Drakenberg T; Nilsson A; Söderberg-ahlm C; Bengtsson B; Olsson H
    J Med Chem; 1995 Jan; 38(1):161-9. PubMed ID: 7837227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid phase synthesis and some pharmacological properties of 8-D-homoarginine-vasopressin and 1-deamino-8-D-homoarginine-vasopressin.
    Gunnar E; Lindeberg G; Melin P; Larsson LE
    Int J Pept Protein Res; 1976; 8(2):193-8. PubMed ID: 1270191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 12. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat.
    Cort JH; Schück O; Stríbrná J; Skopková J; Jost K; Mulder JL
    Kidney Int; 1975 Nov; 8(5):292-302. PubMed ID: 1195561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
    Vávra I; Machová A; Krejcí I
    J Pharmacol Exp Ther; 1974 Jan; 188(1):241-7. PubMed ID: 4809272
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis.
    Tian Y; Sandberg K; Murase T; Baker EA; Speth RC; Verbalis JG
    Endocrinology; 2000 Jan; 141(1):307-14. PubMed ID: 10614652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous antidiuretic activity of antidiuretic hormone antagonists.
    Kinter LB; Caltabiano S; Huffman WF
    Biochem Pharmacol; 1993 May; 45(9):1731-7. PubMed ID: 8494530
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue.
    Morimoto K; Yamaguchi H; Iwakura Y; Miyazaki M; Nakatani E; Iwamoto T; Ohashi Y; Nakai Y
    Pharm Res; 1991 Sep; 8(9):1175-9. PubMed ID: 1724082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of antidiuretic hormone in cold-induced diuresis in the anaesthetized rat.
    Broman M; Källskog O; Nygren K; Wolgast M
    Acta Physiol Scand; 1998 Apr; 162(4):475-80. PubMed ID: 9597114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.